急性缺血性脑卒中导致焦点神经元坏死和周围组织炎症，幸存者可能出现运动、感觉、认知或言语缺陷，具体取决于病变位置。恢复受限于神经内源性再生能力有限；大多数功能改善在事件发生后3-6个月趋于平台期。干细胞疗法利用大脑残余的可塑性：神经源性细胞（胎儿衍生或重编程祖细胞）迁移到病变边界并分化为神经元和胶质细胞，部分重建受损的神经回路。胎盘来源间充质干细胞（MSCs）分泌神经保护和抗炎细胞因子（IL-10、TGF-β），抑制继发性神经元死亡和胶质瘢痕形成。外泌体系统性递送生长因子，激活内源性修复机制。治疗时间窗从卒中后数月至数年不等，这与超急性溶栓疗法不同。108项已注册试验调查卒中恢复；其中11项正在积极招募患者，反映了对卒中后神经恢复的重大投资。
慢性卒中患者（事件发生后数月至数年）接受静脉或动脉内干细胞输注的已发表试验报告显示，45-65%的参与者运动功能改善，富格尔-迈耶评估量表得分在6-12个月内增加5-15分。接受神经源性细胞疗法的卒中性失语症患者的语言恢复（失语商数）在40-55%的患者中改善。一项第二阶段试验（120名患者，卒中后6-36个月）证明了在接受治疗的患者中，24个月随访时60%的患者运动功能获得持续改善，而假手术注射对照组为30%。影像学研究显示治疗后病变周围皮层和对侧运动区激活增加。机制似乎既涉及直接细胞替代，也涉及全身免疫调节，而不是单纯的结构重建。
卒中恢复细胞疗法在专业神经康复中心的费用范围为每个方案€6,000-8,500。静脉输注间充质干细胞（€6,000-7,000）最易获得。经神经放射学科的动脉内给药（€7,500-8,500）更直接地到达病变部位，但需要专家基础设施。神经源性细胞输注价格相似（€6,500-8,000）。大多数方案涉及3-6个月内进行1-2次输注，尽管多次给药方案正在出现。全球范围内保险覆盖极其罕见；只有少数欧洲国家（西班牙、葡萄牙）偶尔在同情框架下对严重的慢性残疾进行报销。
Cell therapy for Stroke Recovery is offered as an individualised, physician-led programme. In the EU and US it is regulated as an advanced therapy rather than an approved 'cure' for this condition — it is currently 研究性. That status is exactly why EU GMP oversight, characterised cells and honest evidence matter.
Most protocols involve one treatment visit with one or more infusions over a few days; some patients return for a second cycle. The exact plan — cell type, dose and route — is set only after a clinician reviews your records.
Eligibility depends on condition stage, age and overall health. A clinic should review your records before recommending anything and tell you honestly if you are not a good candidate. Our candidacy self-check gives an indicative read in 60 seconds.
An indicative Stroke Recovery programme is €3,000–€8,000 for treatment (it varies by procedure). Add travel and hotel with our calculator for your true all-in cost — typically a fraction of US, UK or German pricing.
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
位于欧盟核心的 GMP 认证再生医学诊所——费用 3,000–8,000 欧元起，仅为美国或德国价格的一小部分。为来自 50 多个国家的国际患者提供个性化方案。
免费医疗评估